[ Pobierz całość w formacie PDF ]
17. Valkó K, Du CM, Bevan CD, Reynolds DP, Abraham MH. 2000.
albumin and phospholipid binding correlates with the Rapid-gradient HPLC method for measuring drug interactions
with immobilised artificial membrane: Comparison with other
lipophilicity of the unionised molecules (log P); thus,
lipophilicity measures. J Pharm Sci 89:1085 1096.
in silico lipophilicity can be taken into consideration
18. Valkó K, Du CM, Bevan C, Reynolds DP, Abraham MH. 2001.
when designing compounds.
Rapid method for the estimation of octanol/water partition
coefficient (log Poct) from gradient RP-HPLC retention and a
hydrogen bond acidity term ( 2H). Curr Med Chem 8: 137
1146.
REFERENCES
19. Valkó K. 2004. Measurements of lipophilicity and acid/base
1. Lipinski CA. 2000. Drug-like properties and the causes of poor character using HPLC methods. In Pharmaceutical profiling
solubility and poor permeability. J Pharmacol Toxicol Methods in drug discovery for lead selection; Borchardt RT, Kerns EH,
44:235 249. Lipinski CA, Thakker DR, Wang B, Eds . Arlington, VA: AAPS
2. Wenlock MC, Austin RP, Barton P, David AM, Leeson Press, pp 127 182.
PD. 2003. A comparison of physicochemical property pro- 20. Abraham MH. 1993. Scales of solute hydrogen-bonding: Their
files of development and marketed oral drugs. J Med Chem construction and application to physicochemical and biochem-
46:1250 1256. ical processes. Chem Soc Rev 22:73 83.
3. Van de Waterbeemd H. 2009. Improving compound quality 21. Hollósy F, Valkó K, Hersey A, Nunhuck S, Kri Gy, Bevan C.
through in vitro and in silico physicochemical profiling. Chem 2006. Estimation of volume of distribution from high through-
Biodivers 6:1760 1766. put HPLC-based measurements of human serum albumin
4. Hughes JD, Blagg J, Price DA, Bailey S, DeCrescenzo GA, binding and immobilized artificial membrane partitioning. J
Devraj RV, Ellsworth E, Fobian YM, Gibbs ME, Gilles RW, Med Chem 49:6958 6971.
Greene N, Huang E, Krieger-Burke T, Loesel J, Wager T, 22. Smith DS, van de Waterbeemd H, Walker DK, Mannholds
Whiteley L, Zhang Y. 2008. Physiochemical drug properties as- R, Kubinyi H, Timmerman H, Eds. 2001. Pharmacokinetics
sociated with in vivo toxicological outcomes. Bioorg Med Chem and metabolism in drug design, Chapter 4 , Weinhem: Wiley,
Lett 18:4872 4875. pp 7 66.
5. Brodie BB, Kurtz H, Schanker LJ. 1960. The importance of 23. Lombardo F, Obach RS, Shalaeva MY, Gao F. 2002. Predic-
dissociation constants in lipid solubility on influencing the tion of volume of distribution in humans for neutral and basic
passage of drugs into the CSF. J Pharmacol Exp Ther 130: drugs using physicochemical measurements and plasma pro-
20 25. tein binding data. J Med Chem 45:2867 2876.
6. Trainor GL. 2007. The importance of plasma protein binding 24. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen
in drug discovery. Expert Opin Drug Discov 2:51 64. L, He Z. 2009. Prediction of volume of distribution values in
7. ie S, Tozer TN. 1979. Effect of altered plasma protein human using immobilized artificial membrane partitioning co-
binding on apparent volume of distribution. J Pharm Sci efficients, the fraction of compound ionized and plasma protein
68:1203 1205. binding data. Eur J Med Chem 44:4455 4460.
8. Banker JM, Clark TH, Williams JA. 2003. Development and 25. Rodgers T, Leahy D, Rowland M, 2005. Physiologically
validation of a 96-well equilibrium dialysis apparatus for based pharmacokinetic modelling, part 1: Predicting the tis-
measuring plasma protein binding. J Pharm Sci 92:967 sue distribution of moderate-to-strong bases. J Pharm Sci
974. 94:1259 1276.
9. Wan H, Rehngren M, Giodanetto F, Bergstrom F, Tunek A. 26. Poulin P, Theil FP. 2009. Development of a novel method for
2007. High-throughput screening of drug-brain tissue bind- predicting human volume of distribution at steady-state of ba-
ing and in silico prediction for assessment of central nervous sic drugs and comparative assessment with existing methods.
system drug delivery. J Med Chem 50:4606 4615. J Pharm Sci 98:4941 4961.
10. Waters NJ, Jones R, Williams G, Sohal B. 2008. Validation of 27. Bjrkman S. 2002. Prediction of the volume of distribution of
a rapid equilibrium dialysis approach for the measurement of a drug: Which tissue-plasma partition coefficients are needed?
plasma protein binding. J Pharm Sci 97:4586 4595. J Pharm Pharmacol 54:1237 1245.
11. Valkó K, 2004. Application of high performance liquid chro- 28. Jansson R, Bredberg U, Ashton M. 2008. Pharmacokinetics,
matography based measurements of lipophilicity to model bi- pharmacodynamics and drug metabolism. Prediction of drug
ological distribution. J Chrom 1037:299 310. tissue to plasma concentration ratios using a measured volume
12. Valkó K, Nunhuck S, Bevan C, Abraham MH, Reynolds DP. of distribution in combination with lipophilicity. J Pharm Sci
2003. Fast gradient HPLC method to determine compounds 97:2324 2339.
DOI 10.1002/jps JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 3, MARCH 2011
862 VALK, NUNHUCK, AND HILL
29. Rodgers T, Rowland. 2007. Mechanistic approaches to volume 31. Varma MVS, Obach RS, Rotter C, Miller HR, Chang G, Steyn
of distribution predictions: Understanding the process. Pharm SJ, El-Kattan A, Troutman MD. 2010. Physicochemical space
Res 24:918 933. for optimum oral bioavailability: Contribution of human in-
30. Hosea NA, Collard WT, Cole S, Maurer TS, Fang RX, Jones testinal absorption and first-pass elimination. J Med Chem
H, Kakar SM, Nakai Y, Smith BJ, Webster R, Beaumont K. 53:1098 1108.
2009. Prediction of human pharmacokinetics from preclinical 32. Leeson PD, Springthorpe B. 2007. The influence of drug-like
information: Comparative accuracy of quantitative prediction concept on decision-making in medicinal chemistry. Nat Rev
approaches. J Clin Pharmacol 49:513 533. Drug Discov 6:881 890.
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 3, MARCH 2011 DOI 10.1002/jps
[ Pobierz całość w formacie PDF ]